• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

The University of Texas MD Anderson Cancer Center - Articles and news items


Novartis’ HR+/HER2- advanced breast cancer trial gives superior progression-free survival

Industry news / 10 October 2016 / Niamh Louise Marriott, Digital Content Producer

The results demonstrate that LEE011 plus letrozole reduced the risk of death or progression by 44%. The combination significantly improved PFS across…


Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +